PBE250117P68000
- 0.00
- 0.000.00%
Invesco Biotechnology & Geno Funds Newsroom
8 Health Care Stocks Whale Activity In Today's Session
Looking Into Natera's Recent Short Interest
Trending Stocks as Wall Street Bounces Back With Strong Week
Weekly Buzz: Finally a Good Week for 2025
Wall Street Today: Trump's on Deck After Market Nearly Hits Year High
Argenx Cut to Sell at Deutsche Bank on Valuation
FDA Approves Amgen Treatment For Pretreated Colorectal Cancer With Certain Mutation
The End Of The 60/40 Portfolio
Live Stock News: Market Climbs, TikTok Ban Confirmed, Intel for Sale, Week Ends with Positivity
Nvidia To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Friday
'Ozempic Is In The Next Round Of Medicare Drug Price Negotiations. See The Full List Of 15 Medications' - CNBC
Amgen Announced FDA Approval Of LUMAKRAS Combined With Vectibix For KRAS G12C-Mutated Metastatic Colorectal Cancer; Phase 3 CodeBreaK 300 Study Showed More Than Doubled Progression-Free Survival (5.6 Months) Compared To SOC (2 Months); Primary...
Natera Analyst Ratings
Wall Street Today: Thursday Earnings Looked a Lot More Mixed, and Philly is Booming
Regeneron Pharmaceuticals Analyst Ratings
AbbVie Retains Humira Market Share Above 70%: Report
Live Stock News: Sideways Trading Market After Big TSMC, UNH Earnings, Philly Economy is Booming
"Seladelpar Approved To Treat Adult Patients In The UK With Liver Illness; As With Any Medicine, The MHRA Will Keep The Safety And Effectiveness Of Seladelpar Under Close Review" - UK Gov
$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
Wall Street Today: JPM and Banking Leads Market Higher